Pda Technical Report 82 Pdf May 2026

The report offers hard data on pressure limits, flow rates, and filtration time. It warns that scaling up from lab-scale disc filters to manufacturing-scale cartridges often fails without the guidelines provided in TR-82.

PDA TR-82 does not discard the BET—it refines its interpretation. It acknowledges that absence of detection is not absence of danger. For biotech and pharma quality units, adopting TR-82’s principles means moving from a one-time assay to a product-lifecycle risk management approach.

In an era of increasingly complex biologics, novel excipients, and sensitive routes of administration, TR-82 isn’t just a technical report—it’s an essential update to the safety playbook. pda technical report 82 pdf

PDA Technical Report No. 82 (2020): “Low Endotoxin Recovery” is available for download from the Parenteral Drug Association (PDA).

The report begins with a systematic risk assessment. It asks: Do you truly need sterile filtration, or is low bioburden sufficient? The report offers hard data on pressure limits,

Based on the recommendations in the PDF, here is how to operationalize the report:

Surfactants (e.g., polysorbate 80) or proteins in biopharmaceuticals can encapsulate endotoxin molecules into micelles. The LAL enzyme cannot access the lipid A, producing a false negative. PDA Technical Report No

Container closure systems (glass vials, pre-filled syringes, stoppers) can adsorb endotoxins over time. The liquid phase tests negative, but the endotoxin is physically present on the container wall.